|
EORTC AISBL / IVZW |
|
|
EORTC AISBL / IVZW |
| Trial Status | Open |
| Dates | Date of activation: 23/11/2007 |
| Data management at EORTC | Full |
| Phase | 1 |
| Randomized trial | No |
| Type | Advanced |
| Targeted Sample size | - |
| Number of steps | 1 |
| Drug | Lapatinib (GW572016) |
| Study Staff | Gedske Daugaard (Study Coordinator) - Rigshospitalet, Copenhagen Richard Sylvester (Statistician) - EORTC, Brussels Sarah Morren (Data Manager) - EORTC, Brussels Sandrine Marreaud (Coordinating Physician) - EORTC, Brussels Hilde Breyssens (Project Manager) - EORTC, Brussels, hilde.breyssens( at )eortc.be, +32 2 7741004 Steve Douterlungne (Clinical Research Associate) - EORTC, Brussels |
| Type of cancer | Bladder |
| Participating Groups | EORTC Genito-Urinary Tract Cancer Group(Coordinating Group) |
| Currently authorized centers | Rigshospitalet (Copenhagen, Denmark) - Inst. 401 Herlev Hospital - University Copenhagen (Herlev, Denmark) - Inst. 406 Aarhus University Hospital (Aarhus, Denmark) - Inst. 440 San Camillo Forlanini Hospitals (Roma, Italy) - Inst. 796 Radboud University Nijmegen Medical Centre (Nijmegen, The Netherlands) - Inst. 304 |
| Protocol summary | Link provided by NCI PDQ |
| Protocol documents in PDF (requires password) | 30061.pdf |